There’s one given in life: Things change—and they do so quickly in big brokerages. Therefore, it’s wise for advisors to think ...

Shares of Eli Lilly climbed Wednesday after the drugmaker detailed a study showing that its blockbuster weight-loss drug Zepbound helped patients shed more pounds than Wegovy from rival Novo Nordisk.

The Bombay High Court has ruled that individuals do not have a fundamental right to harass public officials with repeated ...

For Cuban emigrants, returning home is not merely a physical journey but an emotional whirlwind. This was the experience of a ...